Skip Navigation
Skip to contents



31 results

ERRATUM: Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor

Cho JH, Lim JY, Choi AR, Choi SM, Kim JW, Choi SH, Cho JY

  • Cancer Res Treat.
  • 2018 Jan;50(1):302-302.
  • doi: 10.4143/crt.2013.175.2
In this article, a grant number error was found in the Acknowledgments section.
Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study

Joung JY, Kwon WA, Lim J, Oh CM, Jung KW, Kim SH, Seo HK, Park WS, Chung J, Lee KH, Won YJ

  • Cancer Res Treat.
  • 2018 Jan;50(1):293-301.
  • doi: 10.4143/crt.2016.543
PURPOSE: Secondary primary cancers (SPCs) commonly arise in patients with renal cell carcinoma (RCC). We designed the present study to estimate the SPC incidence in Korean patients with RCC. MATERIALS AND...
Clinical Significance of Discordance between Carcinoembryonic Antigen Levels and RECIST in Metastatic Colorectal Cancer

Kim IH, Lee JE, Yang JH, Jeong JW, Ro S, Oh ST, Kim JG, Choi MH, Lee MA

  • Cancer Res Treat.
  • 2018 Jan;50(1):283-292.
  • doi: 10.4143/crt.2016.537
PURPOSE: The purpose of this study was to investigate the prognostic implications of carcinoembryonic antigen (CEA) levels that are inconsistent with Response Evaluation Criteria in Solid Tumor (RECIST) responses in...
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery

Yoon TI, Lee JW, Lee SB, Sohn G, Kim J, Chung IY, Kim HJ, Ko BS, Son BH, Gong G, Kim SB, Kim SS, Ahn SD, Chung M, Ahn SH

  • Cancer Res Treat.
  • 2018 Jan;50(1):275-282.
  • doi: 10.4143/crt.2017.041
PURPOSE: We evaluated the effect of positive superficial and/or deep margin status on local recurrence (LR) in invasive breast cancer treated with breast-conserving surgery (BCS) followed by radiotherapy. MATERIALS AND METHODS:...
Selection Criteria for Active Surveillance of Patients with Prostate Cancer in Korea: A Multicenter Analysis of Pathology after Radical Prostatectomy

Jeong CW, Hong SK, Byun SS, Jeon SS, Seo SI, Lee HM, Ahn H, Kwon DD, Ha HK, Kwon TG, Chung JS, Kwak C, Kim HJ

  • Cancer Res Treat.
  • 2018 Jan;50(1):265-274.
  • doi: 10.4143/crt.2016.477
PURPOSE: Korean patients with prostate cancer (PC) typically present with a more aggressive disease than patients in Western populations. Consequently, it is unclear if the current criteria for active surveillance...
Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in BRCA1 and BRCA2

Hwang SM, Lee KC, Lee MS, Park KU

  • Cancer Res Treat.
  • 2018 Jan;50(1):255-264.
  • doi: 10.4143/crt.2017.062
PURPOSE: Transition to next generation sequencing (NGS) for BRCA1/BRCA2 analysis in clinical laboratories is ongoing but different platforms and/or data analysis pipelines give different results resulting in difficulties in implementation....
FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation

Park J, Choi Y, Ko YS, Kim Y, Pyo JS, Jang BG, Kim MA, Lee JS, Chang MS, Park JW, Lee BL

  • Cancer Res Treat.
  • 2018 Jan;50(1):239-254.
  • doi: 10.4143/crt.2016.580
PURPOSE: Lapatinib is a candidate drug for treatment of trastuzumab-resistant, human epidermal growth factor receptor 2 (HER2)–positive gastric cancer (GC). Unfortunately, lapatinib resistance renders this drug ineffective. The present study...
Nationwide Statistical Analysis of Lymphoid Malignancies in Korea

Lee H, Park HJ, Park EH, Ju HY, Oh CM, Kong HJ, Jung KW, Park BK, Lee E, Eom HS, Won YJ

  • Cancer Res Treat.
  • 2018 Jan;50(1):222-238.
  • doi: 10.4143/crt.2017.093
PURPOSE: Regional differences in the incidence of lymphoid malignancies have been reported worldwide, but there has been no large-scale epidemiologic analysis in Korea. The aim of this study was to...
Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea

Lee TH, Kim W, Shin J, Park EC, Park S, Kim TH

  • Cancer Res Treat.
  • 2018 Jan;50(1):212-221.
  • doi: 10.4143/crt.2016.525
PURPOSE: The purpose of this study was to conduct a cost effectiveness analysis of strategies designed to improve national cervical cancer screening rates, along with a distributional cost effectiveness analysis...
Validation of the Korean Version of the Quality of Life–Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors

Cho J, Kang D, Kim IR, Kim WS, Ferrell B, Kim SJ

  • Cancer Res Treat.
  • 2018 Jan;50(1):204-211.
  • doi: 10.4143/crt.2017.091
PURPOSE: The objective of this study was to validate the Korean version of the Quality of Life–Cancer Survivors (QOL-CS-K) in a sample of lymphoma survivors. MATERIALS AND METHODS: We conducted a...
An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)

Lee SW, Kim YM, Cho CH, Kim YT, Kim SM, Hur SY, Kim JH, Kim BG, Kim SC, Ryu HS, Kang SB

  • Cancer Res Treat.
  • 2018 Jan;50(1):195-203.
  • doi: 10.4143/crt.2016.376
PURPOSE: Genexol-PM is a biodegradable cremophor EL–free polymeric micelle formulation of paclitaxel. Here,we compared efficacy and safety of Genexol-PM plus carboplatin versus Genexol plus carboplatin for ovarian cancer treatment. MATERIALS AND...
The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort Study

Hannouf MB, Winquist E, Mahmud SM, Brackstone M, Sarma S, Rodrigues , Rogan PK, Hoch JS, Zaric GS

  • Cancer Res Treat.
  • 2018 Jan;50(1):183-194.
  • doi: 10.4143/crt.2016.532
PURPOSE: The purpose of this study was to estimate the incidence of occult gastrointestinal (GI) primary tumours in patients with metastatic cancer of uncertain primary origin and evaluate their influence...
Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study

Choi Y, Yun MS, Lim SH, Lee J, Ahn JH, Kim YJ, Park KH, Park YS, Lim HY, An H, Suh DC, Kim YH

  • Cancer Res Treat.
  • 2018 Jan;50(1):175-182.
  • doi: 10.4143/crt.2016.535
PURPOSE: This nationwide retrospective study was conducted to evaluate the efficacy and safety of combined gemcitabine and docetaxel (GD) as an off-label therapy for advanced soft tissue sarcoma, which has...
Epidemiology of Intracranial Metastases in Korea: A National Cohort Investigation

Kim T, Song C, Han JH, Kim IA, Kim YJ, Kim SH, Kim JH, Kim CY

  • Cancer Res Treat.
  • 2018 Jan;50(1):164-174.
  • doi: 10.4143/crt.2017.072
PURPOSE: To investigate the epidemiologic features of intracranial metastases (ICMET) in Korea, we performed a cohort study using the National Health Insurance Service–National Sample Cohort database, which comprised healthcare usage...
Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer

Chung SY, Kim KH, Keum KC, Koh YW, Kim SH, Choi EC, Lee CG

  • Cancer Res Treat.
  • 2018 Jan;50(1):156-163.
  • doi: 10.4143/crt.2016.503
PURPOSE: The purpose of this study was to compare the treatment outcomes of definitive radiotherapy (RT) with cordectomy in patients with early glottic cancer. MATERIALS AND METHODS: A total of 165...
Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study

Amoroso L, Erminio G, Makin G, Pearson AD, Brock P, Valteau-Couanet D, Castel V, Pasquet M, Laureys G, Thomas C, Luksch R, Ladenstein R, Haupt R, Garaventa , SIOPEN Group

  • Cancer Res Treat.
  • 2018 Jan;50(1):148-155.
  • doi: 10.4143/crt.2016.511
PURPOSE: Metastatic response to induction therapy for high-risk neuroblastoma is a prognostic factor. In the International Society of Paediatric Oncology Europe Neuroblastoma (SIOPEN) HR-NBL-1 protocol, only patients with metastatic complete...
Ruthenium-106 Brachytherapy with or without Additional Local Therapy Shows Favorable Outcome for Variable-Sized Choroidal Melanomas in Korean Patients

Cho Y, Chang JS, Yoon JS, Lee SC, Kim YB, Kim JH, Keum KC

  • Cancer Res Treat.
  • 2018 Jan;50(1):138-147.
  • doi: 10.4143/crt.2016.391
PURPOSE: The purpose of this study was to report clinical outcomes of ruthenium-106 (106Ru) brachytherapy with or without additional local therapy for choroidal melanomas in Korean patients. MATERIALS AND METHODS: A...
Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses

Koo KC, Cho JS, Bang WJ, Lee SH, Cho SY, Kim SI, Kim SJ, Rha KH, Hong SJ, Chung BH

  • Cancer Res Treat.
  • 2018 Jan;50(1):129-137.
  • doi: 10.4143/crt.2017.004
PURPOSE: Studies comparing radical prostatectomy (RP) outcomes with those of radiotherapy with or without androgen deprivation therapy (RT±ADT) for prostate cancer (PCa) have yielded conflicting results. Therefore, we used propensity...
Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea

Chang JS, Choi Y, Shin J, Kim KH, Keum KC, Kim HS, Koom WS, Park EC

  • Cancer Res Treat.
  • 2018 Jan;50(1):118-128.
  • doi: 10.4143/crt.2016.575
PURPOSE: Although Korea has the highest incidence of gastric cancer worldwide and D2-lymphadenectomies are routinely performed, radiotherapy (RT) practice patterns have not been well studied. Therefore, we examined RT usage...
Proteomic Biomarkers for Bisphenol A–Early Exposure and Women’s Thyroid Cancer

Lee HS, Kang Y, Tae K, Bae GU, Park JY, Cho YH, Yang M

  • Cancer Res Treat.
  • 2018 Jan;50(1):111-117.
  • doi: 10.4143/crt.2017.001
PURPOSE: For the target treatment and prevention of women's increased thyroid cancer, we focused on risks of environmental exposure to endocrine disrupting chemicals, particularly bisphenol A (BPA), and its high...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: